Ciputra Development Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Ciputra Development Tbk trades at Rp570 (market cap 10.38T, 3.81M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp147 (market cap 576.7B, 2.39M 24h volume). The key difference: Ciputra Development Tbk is far larger — about 18× UBC Medical Indonesia Tbk.'s market cap, and Ciputra Development Tbk is more actively traded (3.81M versus 2.39M). Which is the better fit depends on your goals.
| CTRA | LABS | |
|---|---|---|
Market Cap | 10.38T | 576.7B |
Volume | 3.81M | 2.39M |
Lot | 38.12K | 23.91K |
Turnover | 2.19B | 362.17M |
Average Price | 574.05 | 151.47 |
Value | 2.19B | 362.17M |
Indicative Equilibrium Price | 565 | 147 |
Indicative Equilibrium Volume | 819 | 311 |
Trailing returns across standard periods
Latest headlines on both assets
PT Ciputra Development Tbk (the Company) was established in the Republic of Indonesia originally under the name PT Citra Habitat Indonesia based on notarial deed No. 22 dated October 22, 1981. Ciputra Developments main interest is in residential and township developments which account for approximately 90% of the companies total sales. The company has nine flagship development projects.
Read more on CTRA →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →